Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK

INTRODUCTION: To date there is a lack of economic analysis comparing glucagon-like peptide-1 receptor agonists (GLP-1RAs) to sodium-glucose co-transporter 2 inhibitors (SGLT-2i) for the treatment of type 2 diabetes mellitus (T2DM). Liraglutide and dapagliflozin are the most commonly prescribed GLP-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Vega-Hernandez, Gabriela, Wojcik, Radek, Schlueter, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446377/
https://www.ncbi.nlm.nih.gov/pubmed/28349443
http://dx.doi.org/10.1007/s13300-017-0250-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446377/
https://www.ncbi.nlm.nih.gov/pubmed/28349443
http://dx.doi.org/10.1007/s13300-017-0250-y

Ejemplares similares